Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MERTK | Q12866 | 12/20 | 0.53 |
| ▸ | AXL | P30530 | 9/20 | 0.53 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.52 |
| ▸ | MET | P08581 | 1/20 | 0.52 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.52 |
| ▸ | TACR1 | P25103 | 2/20 | 0.50 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.48 |
| ▸ | PTGES | O14684 | 2/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2064031 | 0.97 | KCNA5 (0.51) | MERTKAXLP2RX7METTYRO3 | |
| SCHEMBL13324324 | 0.86 | P2RX7 (0.52) | MERTKAXLP2RX7METTYRO3 | |
| SCHEMBL12629181 | 0.86 | P2RX7 (0.52) | MERTKAXLP2RX7METTYRO3 | |
| SCHEMBL27701237 | 0.86 | KCNA5 (0.53) | MERTKAXLP2RX7METTYRO3 | |
| SCHEMBL4075331 | 0.84 | P2RX7 (0.50) | MERTKAXLP2RX7METTYRO3 | |
| SCHEMBL13302610 | 0.83 | MERTK (0.49) | MERTKAXLP2RX7METTYRO3 | |
| SCHEMBL8230913 | 0.81 | KCNA5 (0.50) | MERTKAXLP2RX7METTYRO3 | |
| SCHEMBL5435734 | 0.81 | KMT2A (0.54) | MERTKAXLP2RX7METTYRO3 | |
| SCHEMBL5645993 | 0.81 | KMT2A (0.54) | MERTKAXLP2RX7METTYRO3 | |
| SCHEMBL12734545 | 0.81 | KMT2A (0.54) | MERTKAXLP2RX7METTYRO3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007062314-A2 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |